CD19 and infection: In patients undergoing anti-CD19 bispecific T-cell engager (blinatumomab) chemotherapy, Acyclovir has been recommended to prevent Herpes Simplex Virus (HSV) and Varicella Zoster Virus (VZV) infections [19].